Back to 
HighTower Advisors, LLC
HighTower Advisors, LLC
BCTXShowing 0 of 3 quarters
Position history for HighTower Advisors, LLC's holdings in BRIACELL THERAPEUTICS CORP
No. HighTower Advisors exited its BCTX (Briacell Therapeutics) position in Q3 2023. Its Q2 2023 13F listed 16,087 shares worth $104,000. HighTower Advisors first reported BCTX in Q1 2023 and held it in 2 quarterly 13F filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of BCTX: WASATCH ADVISORS LP, Hudson Bay Capital Management LP